Mastalgia

Chetlen, Alison L.; Kapoor, Megha; Watts, Meredith

doi:10.1016/j.acra.2016.10.004

Cited by 20 publications

(3 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[ 15 ] As supported by the literature, the prevalence of mastalgia among women can reach up to 70-80%. [ 10 ] In our study, women with mastalgia accounted for 61.45% of the study population, with an average age of 43.58 years. Additionally, the prevalence of premenopausal participants in the mastalgia group was significantly higher than in the control group (73.91% vs. 59.4%, p=0.001).…”

Section: Discussionmentioning

confidence: 94%

“…However, breast pain is rarely a symptom of breast cancer, occurring in only 0 to 3% of patients subsequently diagnosed with the disease. [9][10][11] Consequently, the differentiation between women with mastalgia and asymptomatic cases based on clinical, radiological, and pathological differences has gained importance in determining follow-up procedures and further testing for mastalgia patients. This study aims to determine the prevalence of mastalgia, identify its underlying risk factors, and explore its relationship with benign and malignant breast diseases.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Identification of Risk Factors for Mastalgia and Its Relationship with Benign or Malignant Breast Diseases

Yigit

2023

Sisli Etfal

View full text Add to dashboard Cite

Objectives Mastalgia is a medical condition that primarily affects women of all age groups. Affected individuals experience excruciating pain, tightness, or a burning sensation in the breast tissue. The aim of this study is to observe the clinicopathologic features of women with mastalgia and compare these features with asymptomatic cases. Methods A total of 524 female patients who applied to the general surgery outpatient clinic were prospectively evaluated. The patients were divided into two groups. Group 1 (G1) included patients with mastalgia, while Group 2 (G2) included asymptomatic patients. The two groups were compared in terms of clinical, radiological, and pathological features. Results This study was conducted on 524 women, among whom the prevalence of mastalgia was found to be 61.45%. There were 322 patients in G1 and 202 patients in G2. The mean age was significantly higher in G2 compared to G1 (46.33±10.33 vs. 43.58±10.33, respectively; p=0.001). Premenopausal women rates for G1 and G2 were 73.91% and 59.4%, respectively (p=0.001). The regular exercise rate in G1 was 18.01%, while it was 25.74% in G2 (p=0.034). The past history of breast cancer rate was significantly higher in G2 than in G1 (p=0.015). The consumption of analgesics was significantly lower in G2 compared to G1 (p=0.05). Non-steroidal anti-inflammatory drugs were the most commonly used analgesic drug class in both groups, with significant intergroup differences (G1: 27.63%, G2: 19.8%, p=0.043). Screening mammography with or without ultrasound examination was performed significantly more often in G2 compared to G1 (66.33% vs. 55.27% and 82.17% vs. 72.98%, p=0.012 and p=0.016, respectively). No significant difference was found concerning the frequency of benign or malignant pathologies between the groups. Conclusion Breast pain is common and should be considered physiological without other breast symptoms and after excluding non-breast causes. It is safe to provide symptom control advice and reassurance to patients who have breast pain but do not have signs or symptoms indicating a possible serious underlying condition requiring further medical intervention.

show abstract

Section: Discussionmentioning

confidence: 94%

mentioning

confidence: 99%

Identification of Risk Factors for Mastalgia and Its Relationship with Benign or Malignant Breast Diseases

Yigit

2023

Sisli Etfal

View full text Add to dashboard Cite

show abstract

“…Even then, no malignancy is identified in most patients with clinically significant mastalgia; in patients with breast pain as their only symptom, the prevalence of breast cancer is 0% to 3.0%. [15][16][17][18][19] The initial imaging modality differs by patient age: younger than 30 years, ultrasonography; between 30 and 40 years, mammography or ultrasonography; and older than 40 years, mammography first followed by ultrasonography. 14 Treatment of breast pain is primarily symptomatic, and evidence for specific treatments is generally lacking.…”

Section: Mastalgiamentioning

confidence: 99%